RPS6KB1 and neoplasm: Western blot assay results in Figure 6D showed that only tumor tissues with the co-administration showed IAPs (cIAP-1/XIAP) degradation, Mcl-1 downregulation as well as S6K1 blockage and profound caspase-3 cleavage/activation (the indicator of cell apoptosis).